AVNRT laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | |||
Depending upon the patient's history and demographics, the following laboratory studies should be considered: | |||
* [[Thyroid function tests]] ([[TFTs]]) - an [[hyperthyroidism|overactive thyroid]] may increase the risk of AVNRT | |||
* [[Electrolyte]]s - [[hypokalemia]], [[hypomagnesemia]] may predispose to AVNRT | |||
* [[Cardiac marker]]s - if there is a concern that [[myocardial infarction]] (a [[heart attack]]) has occurred either as a cause or as a result of the AVNRT; this is usually only the case if the patient has experienced ischemic [[chest pain]] | |||
==References== | ==References== | ||
Revision as of 15:38, 9 September 2012
|
AVNRT Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
AVNRT laboratory findings On the Web |
|
American Roentgen Ray Society Images of AVNRT laboratory findings |
|
Risk calculators and risk factors for AVNRT laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Depending upon the patient's history and demographics, the following laboratory studies should be considered:
- Thyroid function tests (TFTs) - an overactive thyroid may increase the risk of AVNRT
- Electrolytes - hypokalemia, hypomagnesemia may predispose to AVNRT
- Cardiac markers - if there is a concern that myocardial infarction (a heart attack) has occurred either as a cause or as a result of the AVNRT; this is usually only the case if the patient has experienced ischemic chest pain